President Donald Trump announced plans to impose tariffs on imported pharmaceuticals, starting at a lower rate and potentially escalating to 250% within the next year to year and a half.
He emphasized the goal of encouraging domestic manufacturing in key sectors such as healthcare and technology.
Additionally, Trump threatened the European Union with increased tariffs if it fails to meet its $600 billion investment commitment in the United States, labeling the investment as a “gift”